Chair , Department of Molecular Medicine and Therapeutics; Deputy Director for Basic Research
The Ohio State University College of Medicine and Comprehensive Cancer Center
Columbus, OH, United States
Dr. Ringel is Professor and Ralph W. Kurtz Chair of the Department of Molecular Medicine and Therapeutics at The Ohio State University. He also is the Deputy Director for Basic Research of the OSU Comprehensive Cancer Center and Co-director of the Center of Cancer Engineering. Dr. Ringel’s laboratory has defined signaling pathways that regulate thyroid cancer progression and therapeutic resistance and has identified predisposing genes for thyroid cancer. He maintains an active clinical practice focused on thyroid cancer. He is an elected member of the American Society of Clinical Investigation (ASCI) and also the American Association of Physicians (AAP) and has been awarded the Van Meter and Sidney Ingbar Awards from the American Thyroid Association (ATA) as well as the NCI Director’s service award from NIH. He is co-Chair and co-first author of the 2025 ATA Thyroid Cancer Guidelines and is the Editor-in-Chief of Endocrine-Related Cancer.
Disclosure information not submitted.
What's New in the ATA Guidelines for Thyroid Nodules and Differentiated Cancer?
Saturday, October 11, 2025
11:30 AM - 12:20 PM EDT